Option Care Health (NASDAQ:OPCH) Shares Gap Up – Still a Buy?

Option Care Health, Inc. (NASDAQ:OPCH)’s share price gapped up prior to trading on Monday . The stock had previously closed at $23.99, but opened at $27.48. Option Care Health shares last traded at $26.36, with a volume of 535,887 shares changing hands.

Analysts Set New Price Targets

Several equities research analysts have issued reports on OPCH shares. Barrington Research increased their target price on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research report on Tuesday. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $38.00 to $27.00 in a report on Monday, November 4th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. UBS Group began coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. Finally, Truist Financial cut their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $29.86.

Option Care Health Stock Up 3.6 %

The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a fifty day moving average price of $23.33 and a 200 day moving average price of $27.70. The company has a market cap of $4.89 billion, a PE ratio of 24.13, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Institutional investors have recently modified their holdings of the company. Wellington Management Group LLP lifted its holdings in shares of Option Care Health by 15.5% in the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock worth $310,650,000 after acquiring an additional 1,328,326 shares during the last quarter. FMR LLC raised its position in Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after purchasing an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP lifted its stake in Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after purchasing an additional 599,589 shares during the last quarter. State Street Corp boosted its position in Option Care Health by 1.4% during the third quarter. State Street Corp now owns 6,257,172 shares of the company’s stock valued at $195,849,000 after buying an additional 83,395 shares during the period. Finally, Thrivent Financial for Lutherans grew its stake in shares of Option Care Health by 7.4% during the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock valued at $183,541,000 after buying an additional 404,811 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.